Literature DB >> 23843594

Effect of glucose concentration on the stability of daptomycin in peritoneal solutions.

Maria Asunción Parra1, Miguel Angel Campanero, Belen Sádaba, Angel Irigoyen, Laura García-López, Maria Jose Fernandez-Reyes, Jose Ramon Azanza.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23843594      PMCID： PMC3707728          DOI： 10.3747/pdi.2012.00120

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN： 0896-8608            Impact factor:   1.756


× No keyword cloud information.
  11 in total

Review 1.  Peritoneal dialysis solutions.

Authors:  T Wang; B Lindholm
Journal:  Perit Dial Int       Date:  2001       Impact factor: 1.756

2.  Therapeutic serum concentrations of daptomycin after intraperitoneal administration in a patient with peritoneal dialysis-associated peritonitis.

Authors:  Svenja K Bahte; Anna Bertram; Olaf Burkhardt; Jens Martens-Lobenhoffer; Vega Goedecke; Stefanie M Bode-Böger; Marcus Hiss; Jan T Kielstein
Journal:  J Antimicrob Chemother       Date:  2010-04-09       Impact factor: 5.790

3.  Peritoneal dialysis-related infections recommendations: 2010 update.

Authors:  Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Judith Bernardini; Ana E Figueiredo; Amit Gupta; David W Johnson; Ed J Kuijper; Wai-Choong Lye; William Salzer; Franz Schaefer; Dirk G Struijk
Journal:  Perit Dial Int       Date:  2010 Jul-Aug       Impact factor: 1.756

Review 4.  Intraperitoneal administration of drugs in peritoneal dialysis patients: a review of compatibility and guidance for clinical use.

Authors:  Filip de Vin; Peter Rutherford; Dirk Faict
Journal:  Perit Dial Int       Date:  2009 Jan-Feb       Impact factor: 1.756

5.  Intraperitoneal daptomycin.

Authors:  L García-López; L Gómez Sayago; M J Fernández-Reyes Luis
Journal:  Nefrologia       Date:  2011       Impact factor: 2.033

6.  Daptomycin compatibility in peritoneal dialysis solutions.

Authors:  Laure Peyro Saint Paul; Françoise Albessard; Cathy Gaillard; Danièle Debruyne; Jean-Philippe Ryckelynck; Antoine Coquerel; Thierry Lobbedez
Journal:  Perit Dial Int       Date:  2011 Jul-Aug       Impact factor: 1.756

7.  Successful salvage of peritoneal catheter in unresolved methicillin-resistant staphylococcus aureus peritonitis by combination treatment with daptomycin and rifampin.

Authors:  Shih-Yi Lin; Mao-Wang Ho; Jiung-Hsiun Liu; Yao-Long Liu; Hung-Chieh Yeh; Tsung-Lin Hsieh; I-Kuan Wang; Hsin-Hung Lin; Chiu-Ching Huang
Journal:  Blood Purif       Date:  2011-08-12       Impact factor: 2.614

Review 8.  Antimicrobial-resistant gram-positive bacteria in PD peritonitis and the newer antibiotics used to treat them.

Authors:  William Salzer
Journal:  Perit Dial Int       Date:  2005 Jul-Aug       Impact factor: 1.756

9.  Successful use of intraperitoneal daptomycin in the treatment of vancomycin-resistant enterococcus peritonitis.

Authors:  Sarah C Huen; Isaac Hall; Jeffrey Topal; Rex L Mahnensmith; Ursula C Brewster; Ali K Abu-Alfa
Journal:  Am J Kidney Dis       Date:  2009-02-23       Impact factor: 8.860

10.  Stability of tobramycin and ceftazidime in icodextrin peritoneal dialysis solution.

Authors:  Katie E Pallotta; Rowland J Elwell; Adwoa O Nornoo; Harold J Manley
Journal:  Perit Dial Int       Date:  2009 Jan-Feb       Impact factor: 1.756
View more
  6 in total

1.  Intracavitary and Systemic Daptomycin for Successful Treatment of a Postpneumonectomy Intrathoracic Infection.

Authors:  Paloma Sangro; Francisco Carmona-Torre; Miguel Mesa; Jose L Del Pozo; Jose R Yuste
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

2.  Daptomycin Pharmacokinetics in Adolescents Undergoing Hemodialysis and Peritoneal Dialysis: A Case Series With Pharmacokinetic Modeling.

Authors:  Sin Yin Lim; Teresa Lewis; Sukyung Woo; Martin Turman; David W A Bourne; Michael E Burton; Pornpimol Rianthavorn
Journal:  J Pediatr Pharmacol Ther       Date:  2021-02-15

3.  The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis.

Authors:  M Kussmann; L Schuster; M Zeitlinger; P Pichler; G Reznicek; M Wiesholzer; H Burgmann; W Poeppl
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-04       Impact factor: 3.267

4.  Stability of daptomycin in peritoneal dialysis solutions packaged in dual-compartment infusion bags.

Authors:  Sagar Ramdas; Farzana Yousaf; Madhur D Shastri; Troy Wanandy; Syed T R Zaidi; Manish Khandagale; Matthew Jose; Rahul P Patel
Journal:  Eur J Hosp Pharm       Date:  2015-08-20

5.  Stability of daptomycin reconstituted vials and infusion solutions.

Authors:  Javier Sánchez-Rubio Ferrández; Rocío Vázquez Sánchez; Damián Córdoba Díaz; Manuel Córdoba Díaz; María Carmen Lozano Estevan; Teresa Molina García
Journal:  Eur J Hosp Pharm       Date:  2016-03-14

6.  Newer antibiotics for the treatment of peritoneal dialysis-related peritonitis.

Authors:  Terry King-Wing Ma; Chi Bon Leung; Kai Ming Chow; Bonnie Ching-Ha Kwan; Philip Kam-Tao Li; Cheuk Chun Szeto
Journal:  Clin Kidney J       Date:  2016-07-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.